- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00989482
Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics
The purpose of this study is to improve antibiotic prescribing practices of Mexican primary care physicians for patients seeking care for acute respiratory tract infections (ARIs). The investigators will employ a combination of qualitative and quantitative methods to develop and evaluate a patient education and physician decision-support intervention.
Hypothesis 1: The investigators will identify barriers and facilitators of appropriate antibiotic use for ARIs that can be addressed through patient education and physician decision-support.
Hypothesis 2: The proportion of patients who report desire for antibiotics as a "very important" reason for seeking care will decrease from 50% to 30% following exposure to the educational intervention; and 90% (95% confidence interval: 80% to 100%) of patients will report that they trust the information provided by the computer.
Hypothesis 3: Antibiotic prescribing for adults with uncomplicated acute bronchitis will decrease from 80 percent to 40 percent following the introduction of a real-time clinical decision support tool.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Morelos
-
Cuernavaca, Morelos, Mexico
- IMSS Family Practice Clinic #1
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adults age 18 years or greater
Exclusion Criteria:
- mental disability; severe illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Computer Kiosk Eduction
|
computerized patient education; guidelines for physicians
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
antibiotic prescription rate
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fulbright-Gonzales
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Tract Infections
-
Hospices Civils de LyonNot yet recruitingCOVID-19 Infections | Respiratory Infections, AcuteFrance
-
Vastra Gotaland RegionGöteborg University; Sahlgrenska University HospitalNot yet recruitingPneumonia | Respiratory Failure | Respiratory Insufficiency | ARDS (Acute Respiratory Distress Syndrome)Sweden
-
Qingyuan ZhanThe First Affiliated Hospital of Guangzhou Medical University; Wuhan Metware...Not yet recruitingAcute Respiratory Failure | Community-Acquired Pneumonia
-
Washington University School of MedicineNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Hôpital Universitaire SahloulCompleted
-
Wits Health Consortium (Pty) LtdFred Hutchinson Cancer Center; Janssen Vaccines & Prevention B.V.; National Institute... and other collaboratorsCompletedSARS (Severe Acute Respiratory Syndrome)South Africa
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedSevere Acute Respiratory Syndrome Coronavirus 2Canada
-
Pulmoquine Therapeutics, IncRockefeller UniversityCompletedSevere Acute Respiratory Syndrome Coronavirus 2United States
-
University of Cape TownUniversity of KwaZuluUnknownSevere Acute Respiratory Syndrome Coronavirus 2South Africa
-
Massachusetts General HospitalXijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...CompletedCoronavirus | SARS (Severe Acute Respiratory Syndrome)United States, Sweden
Clinical Trials on Computer kiosk Education
-
University of PittsburghCompletedSexually Transmitted Diseases | ContraceptionUnited States
-
SpoedopnameCompleted
-
Johns Hopkins UniversityCompleted
-
Alzheimer's Disease Cooperative Study (ADCS)National Institute on Aging (NIA)CompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Lawson Health Research InstituteLondon Health Sciences CentreCompleted
-
US Department of Veterans AffairsCompleted
-
University of NebraskaCompletedPregnancy RelatedUnited States
-
Duke UniversityUniversity of Alabama at BirminghamCompleted
-
University Health Network, TorontoCompleted
-
Wayne State UniversityUnknownAneuploidy | Autosomal Recessive DisorderUnited States